dopexamine has been researched along with Cardiac Failure in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (62.16) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 1 (2.70) | 29.6817 |
| 2010's | 1 (2.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Stylianakis, GE; Tagarakis, GI; Tsilimingas, NB | 1 |
| Martin, C; Papazian, L; Perrin, G | 1 |
| Blake, DW; McGrath, BP; Trigg, L; Way, D | 1 |
| Rogers, BW; Sziszak, TJ; Sziszak, TL; Taylor, BJ | 1 |
| Asanoi, H; Ishimura, T; Kinoshita, M; Lee, JD; Mitsudo, K; Morioka, S; Sakurai, T; Sasayama, S; Sato, H; Yoshikawa, J | 1 |
| Smit, AJ | 1 |
| Bittner, H; Filcek, S; Friedel, N; Hetzer, R; Kuppe, H; Matheis, G; Wenzel, R | 1 |
| Elkayam, U; Gollub, SB; Haffey, KA; Miller, LW; Young, JB | 1 |
| Böhm, M; Erdmann, E; Reuschel-Janetschek, E | 1 |
| Bristow, MR; Gilbert, EM; Ginsburg, R; Hershberger, RE; Larrabee, P; Mealey, P; Murray, J; Port, JD; Volkman, K | 1 |
| Baumann, G; Felix, SB; Filcek, SA | 1 |
| Baumann, G; Blömer, H; Gerzer, R; Kerscher, M; Stangl, K; Weil, J | 1 |
| van Zwieten, PA | 1 |
| Littler, WA; Murray, RG; Tan, LB | 2 |
| Bayliss, J; Poole-Wilson, P; Thomas, L | 1 |
| Bass, AS; Goldberg, LI; Kohli, JD; Murphy, MB | 1 |
| Böhm, M; Erdmann, E; Kemkes, B; Klövekorn, WP; Pieske, B; Schnabel, P; Schwinger, R | 1 |
| Campese, V; Elkayam, U; Hovanessian, L; Jamison, M; Rahimtoola, SH; Vasquez, J; Weber, L; Widerhorn, J | 1 |
| Drexler, H; Just, H; Meinertz, T | 1 |
| Leier, CV | 1 |
| Kahn, RJ; Reuse, C; Vincent, JL | 1 |
| Borow, KM; Carroll, JD; Ghali, J; Lang, RM; Murphy, MB; Neumann, A; Rajfer, SI; Weinert, L | 1 |
| Foulds, R; Jaski, BE; Serruys, PW; Wijns, W | 1 |
| Erhardt, L; Sjögren, A; Svensson, G | 1 |
| Dhainaut, JF | 1 |
| Binkley, PF; Carpenter, J; Leier, CV; Randolph, PH; Unverferth, DV | 1 |
| Hampton, JR; Murphy, JJ | 1 |
| Foulds, RA | 1 |
| Erhardt, L; Lindvall, B; Strandberg, LE; Svenson, G | 1 |
| Chatterjee, K; De Marco, T; Kwasman, M; Lau, D | 1 |
| Colardyn, FA; Vandenbogaerde, JF | 1 |
| Jaski, BE; Peters, C | 1 |
| Emmot, WW; Gollub, SB; Hassanein, K; Johnson, DE; Sights, KA; Vacek, JL; Wilson, DB | 1 |
| Dawson, JR; Jenkins, BS; Juul, SM; Signy, M; Thompson, DS; Turnbull, P; Webb-Peploe, MM | 1 |
5 review(s) available for dopexamine and Cardiac Failure
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Dopexamine after heart surgery: an uncommonly used, though useful inotropic agent.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Dopamine; Heart Failure; Humans; Splanchnic Circulation; Vasodilation | 2010 |
[Dopexamine: a new dopaminergic agonist].
Topics: Adrenergic Agonists; Animals; Dobutamine; Dogs; Dopamine; Glomerular Filtration Rate; Heart; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Natriuresis; Rats; Receptors, Dopamine; Shock, Septic; Splanchnic Circulation | 1993 |
Dopamine in heart failure and critical care.
Topics: Cardiotonic Agents; Controlled Clinical Trials as Topic; Critical Care; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; Heart Failure; Hemodynamics; Humans; Treatment Outcome | 2000 |
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
Topics: Adrenergic Agonists; Animals; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Nitroprusside | 1989 |
7 trial(s) available for dopexamine and Cardiac Failure
| Article | Year |
|---|---|
Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study.
Topics: Acute Disease; Adult; Aged; Dopamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Single-Blind Method; Substance Withdrawal Syndrome; Vasodilator Agents | 1995 |
Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.
Topics: Adrenergic Agonists; Dopamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1991 |
[Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
Topics: Adrenergic beta-Agonists; Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Clinical Trials as Topic; Cyclic GMP; Dopamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1990 |
Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
Topics: Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vasodilator Agents | 1991 |
Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
Topics: Adult; Aged; Cardiac Output; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Random Allocation; Receptors, Adrenergic; Receptors, Dopamine; Renal Circulation | 1989 |
Cardiovascular pharmacology of dopexamine in low output congestive heart failure.
Topics: Adrenergic Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Output, Low; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renal Circulation; Stroke Volume; Vascular Resistance | 1988 |
Clinical development of dopexamine hydrochloride (Dopacard) and an overview of its hemodynamic effects.
Topics: Cardiovascular System; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation; Heart Failure; Hemodynamics; Humans | 1988 |
25 other study(ies) available for dopexamine and Cardiac Failure
| Article | Year |
|---|---|
Regional blood flow effects of dopexamine versus enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure.
Topics: Anesthesia; Animals; Blood Pressure; Cardiac Output; Dopamine; Doxorubicin; Enalaprilat; Heart Failure; Heart Rate; Hemodynamics; Hindlimb; Kidney; Propofol; Rabbits; Regional Blood Flow; Vasodilator Agents | 1994 |
Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs.
Topics: Animals; Animals, Newborn; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart; Heart Failure; Hemodynamics; Infusions, Intravenous; Isoproterenol; Myocardium; Oxygen Consumption; Propranolol; Receptors, Adrenergic, beta; Sheep; Vasodilator Agents | 1993 |
Haemodynamic effects of different doses of dopexamine hydrochloride in low cardiac output states following cardiac surgery.
Topics: Adrenergic Agonists; Adult; Aged; Aortic Valve; Cardiac Output, Low; Coronary Artery Bypass; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Postoperative Complications | 1992 |
Lack of sustained hemodynamic effects of the beta 2-adrenoceptor agonist dopexamine in end-stage congestive heart failure.
Topics: Adrenergic beta-Agonists; Adult; Dopamine; Heart Failure; Hemodynamics; Humans; Middle Aged | 1990 |
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Ethanolamines; Female; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stimulation, Chemical | 1990 |
Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Time Factors; Urine | 1990 |
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1990 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurosecretory Systems; Nitroglycerin; Time Factors; Vasodilator Agents | 1987 |
Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure.
Topics: Adrenergic beta-Agonists; Aged; Cardiac Output, Low; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Norepinephrine | 1987 |
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug.
Topics: Adrenergic Agonists; Animals; Dogs; Dopamine; Electric Stimulation; Heart; Heart Failure; Infusions, Intravenous; Male; Myocardial Contraction; Neurotransmitter Uptake Inhibitors; Norepinephrine | 1989 |
Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
Topics: Adenylyl Cyclases; Adrenergic Agonists; Adrenergic beta-Antagonists; Binding, Competitive; Dopamine; Female; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Propanolamines; Receptors, Adrenergic, beta | 1989 |
Dopexamine in cardiorespiratory failure. Commentary on drug research in the critically ill.
Topics: Adrenergic Agonists; Dopamine; Heart Failure; Humans | 1989 |
Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure.
Topics: Adrenergic Agonists; Aged; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Respiratory Tract Infections | 1989 |
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
Topics: Adult; Dopamine; Female; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Stress, Mechanical; Systole | 1988 |
The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Dopamine; Drug Evaluation; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Dopamine; Vascular Resistance | 1986 |
Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
Topics: Adrenergic Agonists; Adult; Aged; Chronic Disease; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
A symposium: Focus on heart failure--current experiences in basic research and clinical studies on dopexamine hydrochloride (Dopacard). September 12-13, 1987, Paris, France. Proceedings.
Topics: Adrenergic Agonists; Animals; Dopamine; Heart Failure; Humans | 1988 |
Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
Topics: Adrenergic Agonists; Aged; Chronic Disease; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged | 1988 |
Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
Topics: Aged; Dopamine; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Vasodilator Agents | 1988 |
Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Dopamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Norepinephrine | 1988 |
Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.
Topics: Aged; Analysis of Variance; Cardiac Output; Critical Care; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1988 |
Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Topics: Blood Pressure; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Neurosecretory Systems; Norepinephrine; Vascular Resistance; Vasodilation | 1988 |
Hemodynamic effects of dopexamine hydrochloride infusions of 48 to 72 hours' duration for severe congestive heart failure.
Topics: Adult; Aged; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1988 |
Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
Topics: Adult; Aged; Blood Flow Velocity; Chemical Phenomena; Chemistry; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume; Vascular Resistance | 1985 |